Fig. 1: A timeline depicting the decade of progress in IDH-mutated malignancies.
From: Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
IDH, Isocitrate Dehydrogenase; 2HG, 2-hydroxyglutarate; AML, acute myeloid leukemia; TET2, Ten-Eleven Translocation-2; 2-OG, 2-oxygluterate; AITL, angioimmunoblastic T-cell lymphoma.
